Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyModa Health Corneal CXL Coverage Prior Auth | Open…
    Ask Trek AI about this page
    CurrentModa HealthPolicy N/A

    Corneal Collagen Cross-linking for Treatment of Keratoconus

    Customize your policy alerts

    Sign up for all Moda Health policy alerts

    Know when Moda Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Policy governing coverage and prior authorization requirements for corneal collagen cross-linking (CXL) to treat progressive keratoconus or corneal ectasia after refractive surgery for Moda Health members and providers.

    Policy Summary
    PayerModa Health
    PolicyCorneal Collagen Cross-linking for Treatment of Keratoconus
    Policy CodePolicy N/A
    Change TypeAdministrative — no material clinical changes
    Effective DateJul 1, 2026
    Last ReviewJun 24, 2026
    Next Review DateJun 24, 2026
    Key ActionObtain prior authorization with chart notes documenting diagnosis and a description of the procedure and type of collagen cross-link to be used.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2Covered CPT/HCPCS codes listed
    J2787Riboflavin HCPCS
    0402TProcedure code
    2026-07-01Policy effective

    Coverage Criteria for Corneal Collagen Cross-Linking

    Covered Criteria

    Covered when ALL of the following are met

    Moda Health CXL medical necessity: a. The patient has a diagnosis of progressive keratoconus or corneal keratectasia following refractive surgery.
    Procedure type: b. The requested procedure is for epithelium-off photochemical collagen cross-linkage using riboflavin (HCPC: J2787) and ultraviolet A.
    Exclusion - technique: c. The requested procedure is NOT for epithelium-on collagen cross-linkage (considered experimental/investigational).
    Indication restriction: d. The requested procedure is ONLY indicated for the above diagnoses; all other indications are considered experimental/investigational.

    Epithelium-on (transepithelial) corneal collagen cross-linking (CXL) is explicitly excluded by this policy and is considered experimental and investigational for all indications. Requests for CXL using a transepithelial technique will not meet the coverage criteria described in this policy.

    CXL is considered not medically necessary/experimental when requested for any indication other than progressive keratoconus or corneal keratectasia following refractive surgery. Requests for CXL outside those diagnoses will be denied.

    Relevant Procedure and Diagnosis Codes

    Covered CPT/HCPCS CodesmixedCovered
    0402TCollagen cross-linking of cornea (including removal of the corneal epithelium and intraoperative pachymetry when performed).
    J2787Riboflavin 5'-phosphate, ophthalmic solution, up to 3 mL [Photrexa, Photrexa Viscous]
    Applicable Diagnosis CodesICD-10
    H18.60Keratoconus, unspecified
    H18.601Keratoconus, unspecified, right eye
    H18.602Keratoconus, unspecified, left eye
    H18.603Keratoconus, unspecified, bilateral
    H18.609Keratoconus, unspecified, unspecified eye
    H18.611Keratoconus, stable, right eye
    H18.612Keratoconus, stable, left eye
    H18.613Keratoconus, stable, bilateral
    H18.619Keratoconus, stable, unspecified eye
    H18.62Keratoconus, unstable
    1–10 of 25
    1/3

    Provider Requirements, Authorization, and Documentation

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required before performing corneal collagen cross-linking; submit a prior authorization request that includes chart notes documenting the diagnosis and a description of the procedure. The covered procedure is epithelium-off photochemical collagen cross-linkage using riboflavin (J2787) and ultraviolet A (CPT 0402T listed in coding).

    • Submit chart notes with documentation of diagnosis.
    • Include a description of the planned procedure and type of collagen cross-link to be used.
    • Covered technique: epithelium-off CXL using riboflavin (J2787) and UVA; CPT 0402T applies to the procedure.
    Step Therapy

    Step Therapy / Conservative Management Notes

    Document that conservative management options were considered and discussed with the patient prior to CXL; the policy describes spectacles, rigid gas-permeable contact lenses, intrastromal corneal ring segments, and keratoplasty as alternative or prior options. The policy does not mandate a specific stepwise sequence, but discussion/documentation of these options should be present.

    • Discuss spectacle correction and rigid gas-permeable contact lens use and intolerance if applicable.
    • Document consideration of intrastromal corneal ring segments and keratoplasty where relevant.
    • No specific step-therapy sequence is mandated by the policy.
    Documentation Required

    Required Documentation for PA

    Include chart notes with (1) the clinical diagnosis, (2) a description of the procedure to be performed, and (3) the specific type of collagen cross-link technique planned (epithelium-off with riboflavin/J2787 and UVA).

    • Diagnosis: progressive keratoconus or corneal ectasia following refractive surgery.
    • Procedure description: planned epithelium-off photochemical collagen cross-linkage.
    • Medication/agent: riboflavin ophthalmic solution (J2787) and use of UVA.
    Denial Risk

    Denial Risk — Experimental/Non-covered Indications

    Requests for epithelium-on (transepithelial) CXL or for any indications other than progressive keratoconus or corneal ectasia after refractive surgery are considered experimental/investigational and will be denied.

    • Epithelium-on (transepithelial) collagen cross-linking is explicitly considered experimental and investigational.
    • CXL for indications other than progressive keratoconus or post-refractive surgery ectasia is experimental/investigational and not covered.

    Definitions

    Epithelium-off CXL — definition and key facts
    ProcedureEpithelium-off photochemical corneal collagen cross-linking (CXL) performed after removal of the corneal epithelium using riboflavin ophthalmic solution and ultraviolet A (UVA) light.
    Key componentsRemoval of corneal epithelium, topical riboflavin administration (riboflavin 5'-phosphate ophthalmic solution, HCPCS J2787), followed by UVA irradiation to induce collagen cross-linking.
    Indication per policyCovered only for progressive keratoconus or corneal ectasia following refractive surgery when all coverage criteria are met.
    Coding noteProcedure corresponds to CPT/Category III code 0402T (collagen cross-linking of cornea) and riboflavin is billed with HCPCS J2787.
    Documentation requirementPrior authorization must include chart notes documenting the diagnosis and a description of the procedure and type of collagen cross-link to be used.
    Epithelium-on (transepithelial) CXL — definition and policy status
    TechniqueEpithelium-on (transepithelial) CXL preserves the corneal epithelium during riboflavin and UVA application (no epithelial removal).
    Policy stanceEpithelium-on (transepithelial) collagen cross-linking is considered experimental and investigational and is NOT covered for any indication.
    Coverage implicationRequests for epithelium-on CXL will be denied as experimental/investigational; only epithelium-off CXL meets the policy's covered procedure requirement.
    Indication limitationAll indications other than progressive keratoconus or corneal ectasia after refractive surgery are also considered experimental/investigational.

    Background

    Keratoconus is a progressive, noninflammatory thinning and cone-shaped protrusion of the cornea that can cause visual impairment. Corneal collagen cross-linking (CXL) is a photochemical procedure that uses riboflavin ophthalmic solution in combination with ultraviolet A light to strengthen corneal collagen and slow disease progression. This policy covers epithelium-off photochemical CXL performed with riboflavin (HCPCS J2787) and UVA for members with progressive keratoconus or corneal keratectasia following refractive surgery; other techniques and indications are considered experimental/investigational and are not covered.

    Policy Summary
    PayerModa Health
    PolicyCorneal Collagen Cross-linking for Treatment of Keratoconus
    Policy CodePolicy N/A
    Change TypeAdministrative — no material clinical changes
    Effective DateJul 1, 2026
    Last ReviewJun 24, 2026
    Next Review DateJun 24, 2026
    Key ActionObtain prior authorization with chart notes documenting diagnosis and a description of the procedure and type of collagen cross-link to be used.
    SourceLink
    On This Page
    Coverage Criteria for Corneal Collagen Cross-LinkingRelevant Procedure and Diagnosis CodesProvider Requirements, Authorization, and DocumentationDefinitionsBackground

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.